EMT is a primary process that contributes to the escape of metastatic cancer cells from the primary tumour, as characterised by down-regulation of E-cadherin expression and up-regulation mesenchymal markers (including N-cadherin and vimentin) 11. The gene discussed is CDH2; the disease is neoplasm.